Search
NovaBay Pharmaceuticals Inc
NBYAdd to Watchlist
1.950USD
0.0000.00%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
68.61MMarket Cap
LossP/E TTM
More Details of NovaBay Pharmaceuticals Inc Company
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.
NovaBay Pharmaceuticals Inc Info
Ticker SymbolNBY
Company nameNovaBay Pharmaceuticals Inc
IPO dateOct 26, 2007
CEOKazley (Michael John)
Number of employees14
Security typeOrdinary Share
Fiscal year-endOct 26
Address2000 Powell St Ste 1150
CityEMERYVILLE
Stock exchangeNASDAQ OMX – NASDAQ Basic Amex
CountryUnited States of America
Postal code94608-1804
Phone15108998800
Websitehttps://novabay.com/
Ticker SymbolNBY
IPO dateOct 26, 2007
CEOKazley (Michael John)
Company Executives of NovaBay Pharmaceuticals Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
Mr. Michael Kazley
Mr. Michael Kazley
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Ms. Swan Sit
Ms. Swan Sit
Independent Director
Independent Director
172.00
-10.47%
Mr. Tommy Law
Mr. Tommy Law
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
6.00
+16.67%
Mr. Paul E. Freiman, Ph.D.
Mr. Paul E. Freiman, Ph.D.
Director
Director
--
--
Mr. Justin M. Hall, Esq.
Mr. Justin M. Hall, Esq.
Vice President - Business Development, General Counsel, Corporate Secretary
Vice President - Business Development, General Counsel, Corporate Secretary
--
--
Dr. Yenyou (Jeff) Zheng, Ph.D.
Dr. Yenyou (Jeff) Zheng, Ph.D.
Independent Director
Independent Director
--
--
Capt. Jody Cain
Capt. Jody Cain
IR Contact Officer
IR Contact Officer
--
--
FAQs
Who are the top five shareholders of NovaBay Pharmaceuticals Inc?
The top five shareholders of NovaBay Pharmaceuticals Inc are: Ms. Swan Sit
How many institutions hold shares of NovaBay Pharmaceuticals Inc (NBY)?
As of 2026Q1, 47 institutions hold shares of NovaBay Pharmaceuticals Inc, with a combined market value of approximately 1.80M, accounting for 6.77% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 1464094.00.